Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topiramate efficacy in infancy

S L Kugler1, R C Sachdeo

  • 1Department of Pediatrics, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick 08901, USA.

Pediatric Neurology
|November 27, 1998
PubMed
Summary

Topiramate shows promise for treating partial seizures in infants when other drugs fail. This antiepileptic drug demonstrated excellent efficacy and tolerability in two young infants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Neurology·2004
Same author

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Neurology·2004
Same author

Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.

Epilepsia·2002
Same author

Rapid initiation of gabapentin: a randomized, controlled trial.

Neurology·2001
Same author

Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.

Neurology·2000
Same author

Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group.

Epilepsia·2000

Area of Science:

  • Neurology
  • Pediatric Epilepsy
  • Pharmacology

Background:

  • Topiramate is an established antiepileptic drug for adults with partial onset seizures.
  • Pediatric epilepsy treatment experience with topiramate is limited but shows early promise.
  • Standard antiepileptic drugs (AEDs) may be ineffective for some pediatric patients.

Observation:

  • Two infants, aged 12 and 9 months, with frequent partial seizures were treated with topiramate.
  • The study assessed the efficacy and tolerability of topiramate in these young patients.
  • Doses administered were up to 7.7 mg/kg.

Findings:

  • Topiramate demonstrated excellent efficacy in resolving partial seizures in both infants.
  • The treatment was well-tolerated, with good tolerability observed.
  • Significant seizure reduction was achieved in this small cohort.

Implications:

  • Topiramate may be a viable treatment option for infants with refractory partial seizures.
  • Further research is needed to establish long-term safety and efficacy in pediatric populations.
  • This study supports exploring topiramate for difficult-to-treat epilepsy in very young children.

Related Experiment Videos